ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,634Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1000

$1.45M Total Retail Price of All Prescriptions

Rank: 16 out of 1000

1,062 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,062 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 1,062 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 19,605 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 1,350 875 1 3
HYDROCODONE-ACETAMINOPHEN 1,313 584 S3 2 1
LISINOPRIL 1,029 663 3 5
OMEPRAZOLE 1,000 508 4 2
METFORMIN HCL 777 425 5 8
AMLODIPINE BESYLATE 741 498 6 6
LEVOTHYROXINE SODIUM 670 516 7 4
POTASSIUM CHLORIDE 658 516 8 10
CARVEDILOL 637 360 9 15
GLIPIZIDE 635 403 10 62
HYDROCHLOROTHIAZIDE 574 357 11 9
FUROSEMIDE 553 428 12 7
BUMETANIDE 508 377 13 112
CLONIDINE HCL 496 280 14 27
METOPROLOL TARTRATE 494 301 15 19
TRAMADOL HCL 448 281 16 13
WARFARIN SODIUM 373 310 17 22
CYCLOBENZAPRINE HCL 368 118 R 18 39
CLOPIDOGREL 350 265 19 35
MIRTAZAPINE 345 306 20 56
METOLAZONE 327 281 10 21 167
ACARBOSE 325 219 10 22 268
GABAPENTIN 311 161 23 11
IBUPROFEN 311 125 23 94
AMITRIPTYLINE HCL 293 130 R 25 45
LOSARTAN-HYDROCHLOROTHIAZIDE 281 120 26 38
LOSARTAN POTASSIUM 279 159 27 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 270 143 28 20
LYRICA 263 167 29 47
NEXIUM 263 154 29 23
AMOXICILLIN 253 89 31 89
CRESTOR 249 164 32 30
PLAVIX 247 193 33 49
CIPROFLOXACIN HCL 238 133 34 46
DIOVAN 233 159 35 67
PREDNISONE 219 120 36 42
POLYETHYLENE GLYCOL 3350 218 141 37 69
PRAVASTATIN SODIUM 210 137 38 12
ATORVASTATIN CALCIUM 206 146 39 18
ZOLPIDEM TARTRATE 195 98 40 16
INSULIN SYRINGE 193 116 41 93
DIGOXIN 193 147 41 52
PROAIR HFA 185 106 43 50
NAMENDA 185 185 43 43
SERTRALINE HCL 181 116 45 26
ESCITALOPRAM OXALATE 181 113 45 60
LANTUS 174 104 47 68
DIOVAN HCT 169 56 48 96
PANTOPRAZOLE SODIUM 169 127 48 28
LEVETIRACETAM 165 95 50 128
AZITHROMYCIN 164 89 51 36
HYDRALAZINE HCL 160 90 52 74
QUETIAPINE FUMARATE 152 132 53 75
LEVEMIR 151 124 54 179
NAPROXEN 150 79 55 81
SUCRALFATE 149 91 56 144
DONEPEZIL HCL 149 149 56 32
SPIRONOLACTONE 147 115 58 78
FLUTICASONE PROPIONATE 145 68 59 40
MELOXICAM 143 76 60 14
TAMSULOSIN HCL 134 97 61 33
METOPROLOL SUCCINATE 130 63 62 21
GLYBURIDE 129 79 R 63 92
BENICAR HCT 106 60 64 262
ATENOLOL 103 77 65 24
ENALAPRIL MALEATE 98 83 66 58
LOVASTATIN 96 51 67 41
BENAZEPRIL HCL 93 61 68 61
RANITIDINE HCL 91 52 69 37
TOPIRAMATE 91 0 69 181
FAMOTIDINE 91 74 69 88
BENICAR 89 75 72 263
FLUCONAZOLE 88 23 73 102
RAMIPRIL 86 76 74 77
ALENDRONATE SODIUM 86 76 74 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 48 76 70
METOCLOPRAMIDE HCL 82 71 77 99
OXYBUTYNIN CHLORIDE ER 81 60 78 157
INDOMETHACIN 81 43 R 78 246
PEN NEEDLE 81 32 78 165
PRENATAL PLUS 79 50 81 242
BYSTOLIC 77 49 82 126
VERAPAMIL ER 77 37 82 86
SINGULAIR 76 38 84 84
ADVAIR DISKUS 75 48 85 65
CLOTRIMAZOLE-BETAMETHASONE 74 59 86 173
CITALOPRAM HBR 72 52 87 17
ROPINIROLE HCL 72 45 87 82
HUMULIN R 72 55 87 215
CYPROHEPTADINE HCL 72 52 R 87 297
BUSPIRONE HCL 71 60 91 110
TRAZODONE HCL 69 42 92 29
GLIMEPIRIDE 68 39 93 34
ALLOPURINOL 68 38 93 31
AVODART 68 54 93 214
PAROXETINE HCL 67 12 96 63
LEVEMIR FLEXPEN 66 26 97 205
LIDOCAINE HCL 65 62 98 236
DIVALPROEX SODIUM 64 60 99 113
HUMULIN 70-30 64 25 99 131
CLINDAMYCIN HCL 64 21 99 271
ONGLYZA 63 34 102 221
SPIRIVA 63 43 102 64
VENTOLIN HFA 62 26 104 83
CEPHALEXIN 61 33 105 90
PROMETHAZINE HCL 60 23 R 106 54
GENERLAC 60 60 106 231
LEXAPRO 60 36 106 196
ZETIA 60 28 106 95
ACETAMINOPHEN-CODEINE 58 28 S3 110 127
MONTELUKAST SODIUM 57 24 111 132
FENTANYL 55 45 S2 112 100
AMLODIPINE BESYLATE-BENAZEPRIL 55 33 112 59
MICARDIS 55 48 112 324
LANTUS SOLOSTAR 55 29 112 120
FOSINOPRIL SODIUM 55 14 112 154
DILTIAZEM ER 55 30 112 146
METRONIDAZOLE 54 19 118 281
METHADONE HCL 53 0 S2 119 161
CARAFATE 53 42 119 244
IPRATROPIUM-ALBUTEROL 53 51 119 212
DETROL LA 51 36 122 208
HUMALOG 51 35 122 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.